News

December 10, 2022

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure

December 10, 2022

Dr. Omer Inan shares insight on academia and entrepreneurship – for example, how do they interact…and can a person pursue both?

March 4, 2022

TMCx has progressed virtually in 2020 including Bootcamp, an intensive diligence and relationship building period designed to initiate…

Investigational Device. Limited by Federal (or United States) Law to Investigational Use

© Copyright 2022 by Cardiosense. All Rights Reserved

400 N Aberdeen St Suite 900
Chicago, IL 60642

[email protected]

© Copyright 2022 by Cardiosense. All Rights Reserved